Real-World Effectiveness of Nirmatrelvir/Ritonavir in Preventing Hospitalization Among Patients With COVID-19 at High Risk for Severe Disease in the United States: A Nationwide Population-Based Cohort Study
Zhou et al., medRxiv, doi:10.1101/2022.09.13.22279908
https://c19early.org/zhou8.html